Xcelerate Inc. (XCRT)
OTCMKTS · Delayed Price · Currency is USD
0.0129
-0.0028 (-17.70%)
At close: Mar 6, 2026
Xcelerate Revenue
Xcelerate had revenue of $531.92K in the quarter ending September 30, 2025, a decrease of -30.59%. This brings the company's revenue in the last twelve months to $2.70M, up 380.67% year-over-year. In the year 2023, Xcelerate had annual revenue of $1.12M.
Revenue (ttm)
2.70M
Revenue Growth
+380.67%
P/S Ratio
2.08
Revenue / Employee
224.73K
Employees
12
Market Cap
5.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.12M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2013 | 4.00M | 2.84K | 0.07% |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veltex | 70.13M |
| Selectis Health | 42.17M |
| Regional Health Properties | 37.30M |
| Mid-Atlantic Home Health Network | 27.00M |
| Ethema Health | 15.42M |
| Syra Health | 7.50M |
| Stem Cell Authority | 3.33M |
| HealthLynked | 2.37M |